Can-Fite BioPharma Ltd. (CANF): Business Model Canvas

Key Partnerships

Can-Fite BioPharma Ltd. understands the importance of forming strategic partnerships to drive innovation and growth in the pharmaceutical industry. By collaborating with key partners, Can-Fite is able to leverage expertise, resources, and networks to advance its drug development pipeline and commercialization efforts.

Some of the key partnerships that Can-Fite has established include:

• Collaborations with pharmaceutical firms: Can-Fite has entered into partnerships with pharmaceutical companies to co-develop and commercialize its drug candidates. These collaborations provide access to additional resources, expertise, and market knowledge to accelerate the development and commercialization of new therapies.
• Research partnerships with academic institutions: Can-Fite collaborates with leading academic institutions to conduct preclinical and clinical research on its drug candidates. These partnerships help validate the scientific basis of Can-Fite's drug discovery platform and generate valuable data to support regulatory filings.
• Agreements with clinical research organizations: Can-Fite partners with clinical research organizations to conduct clinical trials for its drug candidates. These partnerships ensure that trials are conducted in compliance with regulatory requirements and ethical standards, while also accelerating patient recruitment and data collection.
• Partnership with licensing and distribution firms: Can-Fite has formed partnerships with licensing and distribution firms to commercialize its products in different regions around the world. These partnerships help maximize the market reach of Can-Fite's products and drive revenue growth through strategic licensing and distribution agreements.

Key Activities

Can-Fite BioPharma Ltd. engages in the following core activities to drive its business model:

• Research & development of novel drugs: The company focuses on developing innovative drugs to target inflammatory, autoimmune, and cancer diseases. This involves extensive research, preclinical studies, and optimization of drug candidates.
• Clinical trials and testing: Can-Fite conducts clinical trials to test the safety and efficacy of its drug candidates in humans. These trials are critical for obtaining regulatory approval and demonstrating the value of the drugs to potential partners and investors.
• Regulatory compliance and approval processes: The company must adhere to strict regulations set by health authorities in various countries. This includes submitting data from clinical trials, ensuring manufacturing practices meet quality standards, and obtaining approvals for commercialization.
• Licensing and patent management: Can-Fite actively seeks partnerships with pharmaceutical companies to further develop and commercialize its drug candidates. The company also manages its intellectual property portfolio to protect its innovations and secure market exclusivity for its products.

Key Partnerships

Can-Fite BioPharma Ltd. collaborates with various partners to support its key activities:

• Contract research organizations (CROs): CROs provide expertise and resources for conducting clinical trials, allowing Can-Fite to efficiently gather data for regulatory submissions.
• Academic research institutions: Partnerships with universities and research centers help the company access cutting-edge scientific knowledge and explore new drug targets.
• Pharmaceutical companies: Licensing agreements with established pharma companies enable Can-Fite to leverage their marketing and distribution capabilities to bring its drugs to market.

Key Resources

The success of Can-Fite BioPharma Ltd. relies on several key resources:

• Talented research team: Scientists and drug development experts drive the company's innovative R&D efforts and ensure the quality of its drug pipeline.
• Financial capital: Funding is essential for advancing drug candidates through the development process, from preclinical studies to clinical trials and regulatory submissions.
• Intellectual property: Patents and other forms of IP protection safeguard Can-Fite's innovations and give the company a competitive advantage in the market.

Key Resources

Scientific and research expertise: Can-Fite BioPharma Ltd. (CANF) boasts a team of highly experienced scientists and researchers who are experts in various fields such as pharmacology, biochemistry, and clinical research. This expertise allows the company to develop innovative drug candidates and conduct cutting-edge research in the field of inflammatory diseases and cancer.

Intellectual property including patents: CANF holds a significant number of patents for its proprietary drug candidates, which provide the company with a competitive advantage in the market. These patents protect the company's inventions and allow it to commercialize its products without fear of infringement from competitors.

Laboratory and clinical infrastructure: CANF has state-of-the-art laboratory facilities equipped with the latest technology and equipment for drug discovery, development, and testing. In addition, the company has access to clinical research organizations (CROs) and clinical trial sites to conduct rigorous testing of its drug candidates in human subjects.

Data from clinical studies and trials: CANF has a wealth of data from preclinical studies and clinical trials conducted on its drug candidates. This data includes safety and efficacy results, pharmacokinetics, and pharmacodynamics data, which are essential for obtaining regulatory approval and advancing the development of its products.

• Scientific and research expertise
• Intellectual property including patents
• Laboratory and clinical infrastructure
• Data from clinical studies and trials

Value Propositions

Can-Fite BioPharma Ltd. offers a range of value propositions that set it apart from other pharmaceutical companies in the industry.

• Innovative drug treatments for inflammatory diseases and cancers: Can-Fite BioPharma Ltd. is dedicated to developing novel drug treatments for inflammatory diseases such as rheumatoid arthritis, psoriasis, and liver disease, as well as various types of cancers. By focusing on these areas of unmet medical need, the company provides hope for patients who may have limited treatment options.
• Targeted therapy with fewer side effects: Can-Fite's drug treatments are designed to target specific pathways and receptors in the body, reducing the risk of side effects commonly associated with traditional therapies. This targeted approach not only improves patient outcomes but also enhances the overall quality of life for those undergoing treatment.
• Cost-effective treatment options for patients: Can-Fite BioPharma Ltd. is committed to developing cost-effective treatment options that are accessible to a wide range of patients. By leveraging its expertise in A3 adenosine receptor technologies, the company is able to create therapies that are both effective and affordable, making a positive impact on healthcare systems worldwide.
• Advanced therapy based on A3 adenosine receptor technologies: Can-Fite's cutting-edge therapy system is built on the foundation of A3 adenosine receptor technologies, which have shown promising results in preclinical and clinical studies. By harnessing the power of these technologies, Can-Fite is able to develop innovative drug treatments that have the potential to transform the standard of care for patients with inflammatory diseases and cancers.

Customer Relationships

Customer relationships are a critical component of Can-Fite BioPharma Ltd.'s business model, as they play a significant role in driving the success of the company. There are several key strategies that the company employs to build and maintain strong relationships with various stakeholders:

Direct engagements with healthcare professionals: Can-Fite BioPharma Ltd. places a strong emphasis on establishing and maintaining direct relationships with healthcare professionals such as doctors, nurses, and pharmacists. The company provides them with up-to-date information on its products, clinical trials, and research findings, and seeks their feedback on how to improve and expand its offerings. This open line of communication helps to ensure that healthcare professionals are well-informed about Can-Fite's products and are confident in recommending them to their patients.

Collaborative partnerships with health institutions: Can-Fite BioPharma Ltd. actively collaborates with health institutions such as hospitals, clinics, and research centers to conduct clinical trials, gather data, and expand its reach in the healthcare industry. By forming strong partnerships with these institutions, Can-Fite can leverage their expertise, resources, and networks to accelerate the development and commercialization of its products.

Support and information provision for patients: Can-Fite BioPharma Ltd. is committed to providing support and information to patients who are using its products or participating in its clinical trials. The company offers educational materials, resources, and customer service channels to help patients understand their treatment options, navigate the healthcare system, and address any concerns or questions they may have. By prioritizing patient support and education, Can-Fite aims to improve patient outcomes and satisfaction.

Regular updates to investors and stakeholders: Can-Fite BioPharma Ltd. maintains transparent and open communication with its investors, shareholders, and other stakeholders through regular updates, reports, and presentations. The company shares key milestones, financial results, strategic initiatives, and industry trends to keep stakeholders informed and engaged. This approach helps to build trust, confidence, and long-term relationships with investors and stakeholders who are critical to the success of the company.

Channels

Can-Fite BioPharma Ltd. utilizes multiple channels to reach its target customers and promote its products. These channels include:

• Direct sales to healthcare providers: Can-Fite BioPharma Ltd. has a dedicated sales team that directly engages with healthcare providers to promote and sell its pharmaceutical products. This direct sales approach allows the company to build relationships with key decision makers in the medical field.
• Distribution through licensed pharmaceutical companies: Can-Fite BioPharma Ltd. partners with licensed pharmaceutical companies to distribute its products to a wider audience. These partnerships enable the company to leverage the existing distribution networks of its partners and reach more customers.
• Online and digital marketing platforms: Can-Fite BioPharma Ltd. utilizes online and digital marketing platforms to promote its products and engage with customers. The company maintains a strong online presence through its website, social media accounts, and email marketing campaigns.
• Scientific conferences and trade shows: Can-Fite BioPharma Ltd. participates in scientific conferences and trade shows to showcase its products and network with industry professionals. These events provide the company with an opportunity to educate potential customers about its products and build credibility within the industry.

Customer Segments

The primary customer segments for Can-Fite BioPharma Ltd. include:

• Patients with inflammatory diseases and cancer: Can-Fite BioPharma focuses on developing drugs that target inflammatory diseases such as rheumatoid arthritis, psoriasis, and liver diseases, as well as various types of cancer. These patients are looking for effective treatments to manage their conditions and improve their quality of life.
• Healthcare institutions and hospitals: Can-Fite BioPharma works closely with healthcare institutions and hospitals to conduct clinical trials, test new drugs, and bring innovative therapies to market. These institutions are interested in partnering with Can-Fite to advance medical research and provide cutting-edge treatments to their patients.
• Pharmaceutical distribution companies: Can-Fite BioPharma collaborates with pharmaceutical distribution companies to commercialize and distribute its drugs globally. These companies play a crucial role in ensuring that Can-Fite's products reach patients in need and are available in various markets.
• Research and academic institutions: Can-Fite BioPharma also partners with research and academic institutions to further its understanding of inflammatory diseases and cancer, as well as to explore new treatment options. These institutions provide valuable expertise, resources, and collaboration opportunities that drive Can-Fite's drug development efforts.

Cost Structure

Can-Fite BioPharma Ltd. incurs various costs in order to maintain and grow its business. The following outlines the key components of the company's cost structure:

Research and Development Expenses:

• Can-Fite BioPharma invests a significant amount of funding into research and development activities in order to discover and develop new drug candidates. This includes costs associated with conducting preclinical studies, clinical trials, and laboratory testing.
• The company also invests in research collaborations with academic institutions and other industry partners to further its drug development efforts.

Clinical Trial and Regulatory Costs:

• As a biopharmaceutical company, Can-Fite BioPharma is required to conduct clinical trials to evaluate the safety and efficacy of its drug candidates. This involves expenses related to patient recruitment, site monitoring, data management, and regulatory submissions.
• The company also incurs costs associated with obtaining and maintaining regulatory approvals for its products in various markets around the world.

Manufacturing and Operational Costs:

• Can-Fite BioPharma is responsible for manufacturing its drug products for use in clinical trials and commercial distribution. This includes expenses related to raw materials, manufacturing facilities, equipment, and personnel.
• The company also incurs operational costs such as rent, utilities, insurance, and general administration expenses.

Marketing and Sales Expenses:

• Once a drug candidate receives regulatory approval, Can-Fite BioPharma incurs marketing and sales expenses to promote the product and generate revenue. This includes costs related to sales force compensation, advertising, distribution, and customer support.
• The company may also invest in market research and promotional activities to increase awareness and adoption of its products.

Revenue Streams

Sales of proprietary drugs:

One of Can-Fite BioPharma Ltd.'s main revenue streams comes from the sales of its proprietary drugs. The company develops and commercializes novel drugs for the treatment of inflammatory and liver diseases. By leveraging its extensive research and development capabilities, Can-Fite is able to bring these drugs to market and generate revenue through sales to healthcare providers and patients.

Licensing fees from patents:

Can-Fite BioPharma also generates revenue through licensing fees from its patented technologies and intellectual property. By licensing its innovations to other pharmaceutical companies, Can-Fite can earn royalties and fees for the use of its proprietary technologies. This provides a steady stream of income for the company and allows it to continue funding its research and development efforts.

Funding from research grants:

Another source of revenue for Can-Fite comes from research grants provided by government agencies, academic institutions, and other organizations. These grants support the company's ongoing research initiatives and help to advance its drug development programs. By securing funding from these external sources, Can-Fite is able to supplement its internal resources and accelerate its research efforts.

Revenue from partnerships and collaborations:

Can-Fite BioPharma also generates revenue through partnerships and collaborations with other pharmaceutical companies, academic institutions, and research organizations. These collaborations may involve joint research projects, co-development agreements, or licensing agreements that provide Can-Fite with additional funding and access to new markets. By leveraging these partnerships, Can-Fite is able to expand its reach, accelerate its drug development programs, and generate revenue through various collaboration opportunities.